Neutropenic mouse thigh infection model (C57BL/6, n = 8 per group). Inoculum: 10⁶ CFU g⁻¹ of A. baumannii AB5075. Treatment: single sub‑cutaneous injection of AKAP‑212 (5 mg kg⁻¹) 2 h post‑infection; vehicle control received PBS. Bacterial load quantified 24 h post‑treatment.
Hemolysis remained below 2 % even at 128 µg mL⁻¹ (32× MIC for the most resistant strain). Cytotoxicity assays indicated a therapeutic index >200. APAK-212
Oil refineries and chemical plants use flare stacks to burn off excess gas. The APAK-212 is increasingly deployed with a UV/IR sensor to monitor pilot flame presence. Using its RS-485 port, the device reports real-time flame status to the plant’s Distributed Control System (DCS). If the flame extinguishes, the APAK-212 can activate an igniter sequence within 200 milliseconds, ensuring compliance with EPA emission standards. Neutropenic mouse thigh infection model (C57BL/6, n =
For pharmaceutical distributors moving mRNA vaccines (which require -70°C storage), the APAK-212 is integrated into custom IoT cold boxes. It connects to four PT-100 temperature probes, logs data every 30 seconds, and transmits alerts via MQTT if any probe deviates from the setpoint. Its wide power input range allows it to run off the same 24V battery system that powers the refrigeration unit. APAK‑2 , isolated from the marine sponge Haliclona spp
Over the next few weeks, Maria and her team deployed APAK-212 in different locations around the city, from industrial areas with high pollution levels to residential neighborhoods. The results were astonishing. The device not only effectively reduced pollutants in the air but also produced clean oxygen at a rate much higher than any existing technology.
Data expressed as mean ± SD. One‑way ANOVA with Tukey’s post‑hoc test (p < 0.05 considered significant).
APAK‑2, isolated from the marine sponge Haliclona spp., displays moderate activity against Gram‑positive bacteria but limited efficacy against Gram‑negatives (Zhang et al., 2018). By employing a structure‑guided redesign—increasing cationic charge, optimizing amphipathicity, and introducing D‑amino acids to confer protease resistance—we generated AKAP‑212, a peptide with a predicted α‑helical conformation and a net charge of +7 at physiological pH.